Trump spoke to reporters in a press conference with Japanese Prime Minister Shigeru Ishiba. When asked whether he would ...

Mainer emphasized the company’s strong cash flow generation, with $310M from operations and $170M in free cash flow. Post repurchased 1.6M shares in Q1 and raised the lower end of FY25 adjusted EBITDA ...

The forward 4-quarter S&P 500 EPS estimate fell to $271.24 this week, after last week’s $273.33 and the prior week’s $273.17.

ING Groep N.V.'s shares underperform in the European financials space, despite solid core capital returns and dividends.

Learn about the significant risks facing the U.S. economy, including mounting debt and geopolitical tensions, and the ...

Financial writer recommends buy rating for Infineon (IFNNY) citing strong AI growth potential and attractive valuation in ...

Financial writer downgrades Trinity Industries to 'hold' due to weakening industry conditions and declining backlog, pending ...

Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Discover the successful decade-long journey of a stock portfolio focusing on dividend growth companies, outperforming the S&P ...

Palantir's key contracts like the Army Vantage extension and TITAN system will benefit the tech giant for some time. Read ...

Equinor ASA shows strong earnings and growth projections for 2025, with a focus on sustainable energy and potential risks.